Assembly Biosciences ASMB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31.12M-46.8% | $58.45M+159% | $22.53M-6.1% | $24.01M+2.5% | $23.41M-38.9% | ||
| $195.48M+3.1% | $189.66M-9.7% | $210.02M+312% | $50.97M-24.6% | $67.62M-8.3% | ||
| $451K-53.7% | $974K+6.8% | $912K— | $0— | -$0— | ||
| $5.56M+1.7% | $5.47M+63.6% | $3.34M+34.4% | $2.49M-44.7% | $4.5M+31.4% | ||
| $232.61M-8.6% | $254.55M+7.5% | $236.81M+206% | $77.47M-18.9% | $95.53M-17.3% | ||
| $214K-3.2% | $221K-3.5% | $229K+4.6% | $219K-12.7% | $251K-11.6% | ||
| $2.37M-5.5% | $2.51M-5.1% | $2.64M-5.0% | $2.78M-5.0% | $2.93M-4.6% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $235.51M-8.6% | $257.59M+7.3% | $240M+197% | $80.78M-18.4% | $99.02M-16.9% | ||
| $1.13M-3.6% | $1.17M-30.4% | $1.68M+127% | $743K-15.1% | $875K+49.6% | ||
| $2.66M-65.6% | $7.75M+35.3% | $5.73M+68.1% | $3.41M+48.0% | $2.3M-66.5% | ||
| $29.08M-21.2% | $36.9M-12.9% | $42.36M+3.5% | $40.92M+0.2% | $40.82M+8.5% | ||
| $590K+3.7% | $569K+3.8% | $548K+2.8% | $533K+0.8% | $529K+14.8% | ||
| $35M-28.3% | $48.78M-8.6% | $53.38M+12.9% | $47.29M+1.4% | $46.63M-2.5% | ||
| $1.9M-7.7% | $2.06M-6.7% | $2.21M-6.1% | $2.35M-5.6% | $2.49M-5.2% | ||
| $36.9M-27.4% | $50.84M-11.3% | $57.3M-8.6% | $62.68M-12.8% | $71.88M-16.2% | ||
| —— | —— | —— | —— | —— | ||
| $16K0.0% | $16K0.0% | $16K+100% | $8K0.0% | $8K+14.3% | ||
| $1.04B+0.1% | $1.04B+0.2% | $1.04B+20.1% | $863.31M+0.1% | $862.12M+0.3% | ||
| -$841.13M-1.1% | -$832.05M+2.6% | -$854.14M-1.1% | -$844.94M-1.2% | -$834.74M-1.1% | ||
| -$368K-798% | -$41K+54.4% | -$90K+67.7% | -$279K-10.3% | -$253K-19.9% | ||
| $198.61M-3.9% | $206.75M+13.2% | $182.7M+909% | $18.1M-33.3% | $27.13M-18.7% | ||
| $235.51M-8.6% | $257.59M+7.3% | $240M+197% | $80.78M-18.4% | $99.02M-16.9% | ||
| $195.48M+3.1% | $189.66M-9.7% | $210.02M+312% | $50.97M-24.6% | $67.62M-8.3% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $2.37M-5.5% | $2.51M-5.1% | $2.64M-5.0% | $2.78M-5.0% | $2.93M-4.6% | ||
| $2.37M-5.5% | $2.51M-5.1% | $2.64M-5.0% | $2.78M-5.0% | $2.93M-4.6% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $2.37M-5.5% | $2.51M-5.1% | $2.64M-5.0% | $2.78M-5.0% | $2.93M-4.6% | ||
| $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | $312K0.0% | ||
| $1.54M-35.6% | $2.39M-21.9% | $3.06M+80.8% | $1.69M-19.7% | $2.11M-7.3% | ||
| $2.49M-5.2% | $2.63M-4.6% | $2.76M-4.5% | $2.88M-4.5% | $3.02M-2.2% | ||
| $1.04B+0.1% | $1.04B+0.2% | $1.04B+20.1% | $863.31M+0.1% | $862.12M+0.3% | ||
| $16K0.0% | $16K0.0% | $16K+100% | $8K0.0% | $8K+14.3% | ||
| $2.66M-65.6% | $7.75M+35.3% | $5.73M+68.1% | $3.41M+48.0% | $2.3M-66.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Assembly Biosciences's total assets?
- Assembly Biosciences (ASMB) holds $235.5M in total assets, up 137.8% year over year.
- How much debt does Assembly Biosciences have?
- Assembly Biosciences carries $2.5M in total debt against $198.6M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Assembly Biosciences have?
- Assembly Biosciences holds $31.1M in cash and equivalents.
- Can Assembly Biosciences cover its short-term obligations?
- Its current ratio is 6.65 — current assets exceed current liabilities.
- Where does Assembly Biosciences's balance sheet data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
